Thrombolytische Therapieformen im Kindesalter

H. G. Kehl; H. Vielhaber; Ulrike Nowak-Göttl

doi:10.1055/s-0038-1656659

Hämostaseologie, Table of Contents

Hamostaseologie 1996; 16(04): 212-216
DOI: 10.1055/s-0038-1656659

Übersichtsarbeiten/Review Articles

Schattauer GmbH

Thrombolytische Therapieformen im Kindesalter

Eine Übersicht

Authors

H. G. Kehl

¹Westfälische Wilhelms-Universität Münster, Klinik und Poliklinik für Kinderheilkunde, Kardiologie (Direktor: Prof. Dr. med. J. Vogt)
H. Vielhaber

¹Westfälische Wilhelms-Universität Münster, Klinik und Poliklinik für Kinderheilkunde, Kardiologie (Direktor: Prof. Dr. med. J. Vogt)
Ulrike Nowak-Göttl

¹Westfälische Wilhelms-Universität Münster, Klinik und Poliklinik für Kinderheilkunde, Kardiologie (Direktor: Prof. Dr. med. J. Vogt)

Abstract

PDF Download

Zusammenfassung:

Thrombosen und Embolien sind im Kindesalter nicht zu unterschätzen. Typische Ursachen sind zentrale Katheter, Herzkatheteruntersuchungen mit Intervention, größere operative Eingriffe neben primären oder sekundären Mangelzuständen von Gerinnungsinhibitoren. Geschätzt wird eine Inzidenz von etwa 5 auf 10000 hospitalisierte Kinder mit einer Mortalität von 2%, einer Rezidivrate von 7-18% sowie der Entwicklung postthrombotischer Syndrome in 20% der Fälle. Die Erfahrungen mit thrombolytischen Therapieformen im Kindesalter sind begrenzt. In mehreren Studien gut dokumentiert sind Thrombolysen von akuten Verschlüssen der Femoralarterien nach Herzkatheruntersuchungen: In 10 Studien wurden 147 von 164 (90%) Patienten erfolgreich lysiert, lokale Blutungen traten bei 41 von 164 (25%) auf. Auf kleinere Studien begrenzt sind Therapien von Thrombosen in den Nierenvenen, den zentralvenösen Gefäßen sowie im rechten Atrium. Erfahrungen mit Lysen linksatrialer, linksventrikulärer oder aortaler Thrombosen sowie Lungenembolien im Kindesalter liegen bisher nur in Form von Kasuistiken vor.

Schlüsselwörter

Thrombolyse - Thrombose - Embolie - Kinder

PDF (7441 kb)

References

LITERATUR
1 Andrew M, Brooker L, Leaker M. et al. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost 1992; 68: 325-30.
2 Asante-Korang A, Sreeram N, McKay R, Arnold R. Thrombolysis with tissue-type plasminogen activator following cardiac surgery in children. Int J Cardiol 1992; 35: 317-22.
3 Bhat R, Fisher E, Doshi U. et al. Neonatal abdominal aortic thrombosis. Crit Care Med 1981; 9: 858-61.
4 Bromberg WD, Firlit CF. Fibrinolytic therapy for renal vein thrombosis in the child. J Urol 1990; 143: 86-8.
5 Brus F, Witsenburg M, Hofhuis WJ. et al. Streptokinase for femoral artery thrombosis after arterial catherterisation in infants and children. Br Heart J 1990; 63: 291-4.
6 Corrigan JJ, Jeter M, Allen HD, Malone JM. Aortic thrombosis in a neonate: failure of urokinase thrombolytic therapy. Am J Pediatric Hematol Oncol 1982; 4: 243-7.
7 Curnow A, Idowu J, Behrens E. et al. Urokinase therapy for silastic catheter-induced intravascular thrombi in infants and children. Arch Surg 1985; 120: 1237-40.
8 David M, Andrew M. Venous thrombem-bolic complications in children. J Pediatr 1993; 123: 337-46.
9 David M, Manco-Johnson Andrew M. Diagnosis and treatment of venous thrombem-bolism in children and adolescents. Thromb Haemost 1995; 74: 791-2.
10 Delaplane D, Scott JP, Riggs TW. et al. Urokinase therapy for a catheter related right atrial thrombus. J Pediatr 1982; 100: 149-52.
11 Dillon PW, Fox PS, Berg CJ. et al. Recombinant tissue plasminogen activator for neonatal and pediadric vascular thrombolytic therapy. J Pediatr Surg 1993; 28: 1264-9.
12 Emami A, Saidanha R, Knupp C, Kodroff M. Failure of systemic thrombolytic and heparin therapy in treatment of neonatal aortic thrombosis. Pediatrics 1987; 79: 773-7.
13 Gault DT. Vascular compromise in newborn infants. Arch Dis Childh 1992; 67: 463-7.
14 Goldberg RE, Cohen AM, Bryan PJ. et al. Neonatal aortic thrombosis treated with intra-arterial urokinase therapy. Can Assoc Radiol J 1989; 40: 55-6.
15 Hassall E, Ulich T, Ament ME. Pulmonary embolus and Malassezia pulmonary infection related to urokinase therapy. J Pediatr 1983; 102: 722-5.
16 Häusler HJ, Schneider P. Inferior vena cava thrombus in infants. Pediatr Cardiol 1992; 13: 240
17 Hausmann D, Gulba D. et al. Bargheer Successful thrombolysis of an aortic-arch thrombus in a patient after mesenteric embolism. N Engl J Med 1992; 327: 500-1.
18 Ino T, Benson LN, Freedom RM. et al. Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J 1988; 115: 633-9.
19 Jolly N, Kaul UA, Khallilullah M. Right atrial thrombus over eustachian valves -successful lysis with streptokinase. Int J Cardiol 1991; 30: 354-6.
20 Kennedy LA, Drummond WH, Knight ME. et al. Successful treatment of neonatal aortic thrombosis with tissue plasminogen activator. J Pediatr 1990; 116: 798-801.
21 Kirk CR, Qureshi SA. Streptokinase in the management of arterial thrombosis in infancy. Int J Cardiol 1989; 25: 15-20.
21b Kirk CR, Bhrolchain NC, Qureshi SA. Streptokinase for aortic thrombosis. Arch Dis Childh 1988; 65: 1086-7.
22 Koska J, Kunichika ET, Pepine CJ, Wagman AJ. Successful use of low-dose tissue plasminogen activator for treatment of thrombosed prosthetic valve in a 22-month-old child. Am Heart J 1990; 120: 978-80.
23 Kothari SS, Varma S, Wasir HS. Thrombolytic therapy in infants and children. Am Heart J 1994; 127: 651-7.
24 Krogmann ON, Kries R, Schreiber R. Thrombosen bei herzkranken Kindern und deren Behandlung. In:. Sutor AH. (Hrsg.). Thrombosen im Kindesalter. Basel: Editiones Roche; 1992: 47-54
25 Le Blanc JG, Culham JA, Chan KW. Treatment of grafts and major vessel thrombosis with low dose streptokinase in children. Ann Thorac Surg 1986; 41: 630-5.
26 Levy M, Benson LN, Burrows PE. et al. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr 1991; 118: 467-72.
27 Marder V, Sherry S. Thrombolytic therapy: Current status (Two parts). N Engl J Med 1988; 318 1512-20 and 1585-95.
28 Marsh D, Wilkerson S, Cook L, Pietsch J. Right atrial thrombus in neonates receiving central venous lines after extracorporal membrane oxygenation. Crit Care Med 1988; 16: 202-3.
29 Metha S, Connors A, Danish EH, Grisoni E. Incidence of thrombosis during central venous catheterization of newborns: A prospective study. J Pediatr Surg 1992; 27: 18-22.
30 Nowak-Göttl U, Schwabe D, Schneider W. et al. Thrombolysis with recombinant tissue-type plasminogen activator in renal venous thrombosis in infancy. Lancet 1992; 340: 1105
31 Olsen MM, Blumer JL, Gauderer WL, Izant RJ. Streptokinase dissolution of a right atrial thrombus. J Pediatr Surg 1985; 20: 19-21.
32 Pongiglione G, Marasini M, Ribaldone D. et al. Right atrial thrombus in two premature infants: successful treatment with urokinase and heparin. Eur Heart J 1986; 7: 1086-9.
33 Pritchard SL, Culham JAG, Rogers PCJ. Low dose fibrinolytic therapy in infants. J Pediatr 1985; 106: 594-8.
34 Pyles LA, Pierpont MEM, Steiner ME. et al. Fibrinolysis by tissue plasminogen activator in a child with pulmonary embolism. J Pediatr 1990; 116: 801-4.
35 Reidy SJ, O'Hara PA, O' Brien P. Streptokinase use in children undergoing cardiac catheterization. J Cardiovasc Nurs 1989; 4: 46-56.
36 Reznik VM, Anderson J, Griswold WR. et al. Successful fibrinolytic treatment of arterial thrombosis and hypertension in a cocaine-exposed neonate. Pediatrics 1989; 84: 735-8.
37 Ries M, Singer H, Hofbeck M. et al. Systemische und lokale Thrombolyse mit rt-PA (Actilyse) bei Kindern mit angeborenen Herzfehlern. Monatsschr Kinderheilkd 1994; 142: 205-8.
38 Rogers PC, Silva MP, Carter JE, Wadsworth LD. Renal vein thrombosis and response to therapy in a newborn due to protein C deficiency. Eur J Pediatr 1989; 149: 124-5.
39 Schreiber R, Schuhmacher G, Bühkmeryer K. Arterial thrombosis following retrograde catheterization in children: noninvasive recanalization by systemic fibrinolytic therapy. In:. Doyle EF, Engle MA, Ger-sony WM, Raskind WJ, Talner NS. (eds). Pediatric Cardilogy. Proceedings of the Second World Congress. Heidelberg: Springer; 1986: 364-9
40 Seifried E, Transwell P, Rijken DC. et al. Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteers. Drug Res 1988; 38: 418-22.
41 Strife JL, Ball WS, Towbin R. et al. Arterial occlusion in neonates: use of fibrinolytic therapy. Radiology 1988; 166: 395-400.
42 Suarez CR, Ow EP, Lambert GH. et al. Urokinase therapy for a central venous catheter thrombosis. Am J Hematol 1989; 31: 269-72.
43 Vailas GN, Brouillette RT, Scott JP. et al. Neonatal aortic thrombosis: recent experience. J Pediatr 1986; 109: 101-8.
44 Van Overmeire B, Van Reempts PJ, Van Acker KJ. Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator. Arch Dis Child 1992; 67: 443-5.
45 Wessel DL, Keane JF, Fellows KE. et al. Fibrinolytic therapy for femoral arterial thrombosis after cardiac catherterization in infants and children. Am J Cardiol 1986; 58: 347-51.
46 Zenz W, Muntean W, Beitzke A. et al. Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterization in infants and children. Br Heart J 1993; 70: 382-5.
47 Zenz W, Muntean W, Zobel G, Beitzke A. A tissue plasminogen activator in combination with heparin for treatment of femoral artery thrombosis in infants and children. Fibrinolysis 1994; 8 (Suppl. 01) 71
48 Zureikat GY, Martin GR, Silverman NH, Newth CJ. Urokinase therapy for a catheter-related right atrial thrombus and pulmonary embolism in a 2-month-old infant. Pediatr Pulmonol 1986; 2: 303-6.